Back to results
US 2022/0031694 A1Published application
Combination product of bcl-2 inhibitor and mdm2 inhibitor and use thereof in the prevention and/or treatment of diseases
AssigneeAscentage Pharma (Suzhou) Co., Ltd.
InventorsDajun YANG, Yifan ZHAI, Qiuqiong TANG, Douglas Dong FANG
Life of this patent
Estimating the term…
Abstract
Provided herein is a combination product comprising a Bcl-2 inhibitor and an MDM-2 inhibitor, the combination product providing a use in the prevention and/or treatment of diseases (e.g., cancer).
Claims22
A combination product comprising a Bcl-2 inhibitor and an MDM2 inhibitor.
(canceled)
(canceled)
A method of treating a cancer, comprising administering to a subject in need thereof a prophylactically and/or therapeutically effective amount of:
- (i) a Bcl-2 inhibitor, and (ii) an MDM2 inhibitor.
Dependencies are inferred from the claim text.